Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer

被引：0
|
作者：
Muhammad Wasif Saif
K. I. Syrigos
S. Hotchkiss
J. Shanley
J. Grasso
T. M. Ferencz
K. Syrigos
M. M. Shah
机构：
[1] Yale University School of Medicine,Section of Medical Oncology
[2] Athens School of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 65卷
关键词：
Cetuximab (Erbitux); Panitumumab; Epidermal growth factor receptor (EGFR); Colorectal cancer; Hypersensitivity reaction; Infusion reaction; Desensitization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：107 / 112
页数：5
相关论文
共 50 条
  • [1] Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer
    Saif, Muhammad Wasif
    Syrigos, K. I.
    Hotchkiss, S.
    Shanley, J.
    Grasso, J.
    Ferencz, T. M.
    Syrigos, K.
    Shah, M. M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 107 - 112
  • [2] Successful administration of panitumumab alone after severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer
    Cartwright, Thomas H.
    Genther, Renee
    CLINICAL COLORECTAL CANCER, 2008, 7 (03) : 202 - 203
  • [3] Successful desensitization with cetuximab (CET) after hypersensitivity reaction (HSR) to panitumumab (PAN) and CET in patients (pts) with metastatic colorectal cancer (mCRC)
    Shah, M. M.
    Hotchkiss, S.
    Shanley, J.
    Davies, M. J.
    Ferencz, T. M.
    Syrigos, K. I.
    Syrigos, K.
    Saif, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Treatment with panitumumab after a severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer: A case report
    Heun, James
    Holen, Kyle
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 529 - 531
  • [5] Successful desensitisation with cetuximab (CET) after hypersensitivity reaction (HSR) to panitumumab (PAN) and CET in patients with metastatic colorectal cancer (mCRC)
    Syrigou, E.
    Shah, M.
    Kotteas, E.
    Alamara, C.
    Saif, M.
    Syrigos, K.
    ALLERGY, 2008, 63 : 375 - 375
  • [6] Clinical benefit of panitumumab after cetuximab failure in patients with metastatic colorectal cancer
    Haraldsdottir, Sigurdis
    Wu, Christina Sing-Ying
    Rose, Jeffrey Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] EFFICACY OF CETUXIMAB/PANITUMUMAB AFTER PREVIOUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Gherman, Alexandra
    Cainap, Calin
    Vesa, Stefan-Cristian
    Havasi, Andrei Dan
    Trifon, Alexandra
    Cainap, Simona Sorana
    Crisan, Ovidiu
    Irimie, Alexandru
    FARMACIA, 2020, 68 (04) : 656 - 664
  • [8] Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer
    Yokokawa, Hideyuki
    Kono, Teppei
    Shidei, Hiroaki
    Oyama, Kunihiro
    Ito, Yoshitomo
    Imaizumi, Rie
    Miyano, Yutaka
    Shiozawa, Shunichi
    Yoshimatsu, Kazuhiko
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2021, 10 (01) : 87 - 90
  • [9] Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer
    Hideyuki Yokokawa
    Teppei Kono
    Hiroaki Shidei
    Kunihiro Oyama
    Yoshitomo Ito
    Rie Imaizumi
    Yutaka Miyano
    Shunichi Shiozawa
    Kazuhiko Yoshimatsu
    International Cancer Conference Journal, 2021, 10 : 87 - 90
  • [10] Panitumumab Monotherapy in Patients with Metastatic Colorectal Cancer and Cetuximab Infusion Reactions: A Series of Four Case Reports
    Langerak, Alan
    River, George
    Mitchell, Edith
    Cheema, Puneet
    Shing, Mona
    CLINICAL COLORECTAL CANCER, 2009, 8 (01) : 49 - 54
12345